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Review article 
Ανασκόπηση
ABSTRACT: Rabbit hemorrhagic disease (RHD) is considered as one of the most important viral diseases that af-
fects and threatens rabbit’s flocks. This disease has affected rabbits since mid-1980. Two epidemics of RHD had been 
discovered; the first was in mid-1980 and known as classical RHD virus (RHDV), while the second was in 2011 and 
described as variant virus (RHDVb/RHDV2). Domestic and wild rabbits are susceptible to RHD. All ages can be 
affected, but adults are more susceptible to young kitten. RHD is presented in three forms; per-acute, acute and sub-
acute or chronic form. Mortality rate is usually high especially in per-acute and acute stages and it is associated with 
disseminated intravascular coagulopathy and necrotic hepatitis. The main lesions have been observed in the liver, 
lungs and spleen. Diagnosis of RHD is based on the clinical picture and detection of RHDV or specific antibodies. 
The prevention and control strategies depend mainly on using of preventive inactivated vaccine together with adoption 
of hygienic measures. However, there is no specific treatment of RHDV infection. So, this review article puts a spot 
light on RHD regarding the epidemiology, the clinical and laboratory diagnosis as well as the prevention and control 
strategies with a special reference to Egyptian situation.
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INTRODUCTION
Egypt is considered as the fourth largest country that produce rabbit meat worldwide (FAO, 2019). 
Egyptians prefer rabbit’s meat for its great benefits 
and for the characteristics of carcass traits (Albogh-
dady and Alashry, 2010). An improvement of rabbit 
industry is a goal to solve the shortage of meat after 
poultry industry. 
Rabbits are highly susceptible to many serious 
diseases problems that have adverse effects on rab-
bits industry in Egypt (Hamed et al., 2013). One of 
these diseases is rabbit hemorrhagic disease (RHD) 
which has been considered as fetal, highly conta-
gious, and world-wide viral disease. This disease was 
also previously named as rabbit viral sudden death, 
hemorrhagic septicemia syndrome, viral hemorrhagic 
pneumonia and rabbit viral hemorrhagic disease (Mi-
tro and Krauss, 1993). RHD induces great and signif-
icant economic importance in terms of high mortality 
and morbidity as well as great losses in meat and fur 
production of Egypt (Mohamed, 2009; Fahmy et al., 
2010). RHD is notifiable as authorities should be im-
mediately reported in case of outbreaks (OIE, 2018). 
RHD is caused by RHD virus (RHDV) which is be-
longing to Calicivirus family and Lagovirus genus. 
There is only one serotype for all classical pathogenic 
strains of RHDV, however, two subtypes, RHDV and 
RHDVa, have been found (CFSPH, 2006). In 2011, 
other variant virus (RHDVb/RHDV2) have also been 
recorded. Acute RHD infection is characterized by 
sudden respiratory and nervous manifestations as 
well as by high mortality due to disseminated intra-
vascular coagulopathy. There is no specific treatment, 
however, prevention of RHD is based mainly on us-
ing of vaccines as well as adoption of hygienic mea-
sures (ITAVI, 2019).
Serious studies have been conducted in Egypt to 
update the epidemiological situation of RHD among 
rabbit farms (Awad and Kotb, 2018; Magouzi et al., 
2019; Erfan and Shalaby, 2020) and to spotlight on 
vaccine production trials (Abd El-Motelib et al. 1998; 
Khodeir and Daoud, 2002; Eid and Ibraheem, 2006).
Thus, this article review focuses on rabbit hemor-
rhagic disease regarding the epidemiology, the clin-
ical and laboratory diagnosis as well as the preven-
tion and control strategies with a special reference to 
Egyptian situation.
HISTORY AND INCIDENCE
The first clinical report of RHD was in 1980s in 
China where the disease killed 14 million of Europe-
an Angora rabbits within 9 months (Liu et al., 1984). 
A year later in China, Xu (1991) recorded death of 
140 million domestic rabbits due to RHD. Later, the 
disease showed rapid spread to Italy (Cancellotti and 
Renzi, 1991) and became endemic in several Europe-
an, Australian, New Zealand, Asian and African coun-
tries (Berninger and House, 1995; Kovalisk, 1998; Le 
Gall-Recule et al., 2003; Alda et al., 2010; Abrantes 
et al., 2012). 
The first record of RHDV in Egypt was in spring 
of 1991, in El-Sharkia governorate, where the vi-
rus was associated with 90% mortality rate (Gha-
nem and Ismail, 1992). Later, RHD was recorded 
in El-Kaluobia governorate (Sharawi, 1992). Salem 
and El-Ballal (1992) detected presence of RHDV in 
Upper Egypt (Assiut) governorate in winter of 1992. 
In 1993, RHDV was isolated from 14-16 week-old 
rabbits with 26.7%-100% losses in El-Minya, Assiut 
and Sohag governorates (El-Zanaty, 1994). Since 
this time, subsequent disease outbreaks have been 
recorded in different Egyptian governorates. During 
the period from 1994 to 1996, about 25 outbreaks of 
circulating RHDV were demonstrated in Cairo, Giza, 
El-Kalubia, Kafr-El-Sheikh, El-Dakahlia, El-Gharbia 
and Marsa-Matroh governorates (El-Mongy, 1998). 
Both RHDV and Pasteurella multocida (P. multoci-
da) had been found in three cases of rabbits in Alex-
andria governorate (Ibrahim et al., 1999). In 2000, in 
Assuit governorate, clinical picture of epistaxis, inco-
ordination of the gait, convulsion and vaginal bloody 
exudate were observed in rabbit flocks with RHDV 
(Abd El-Ghafar et al., 2000). Although presence of 
restricted regimen program for vaccination of Egyp-
tian rabbit flocks against RHDV, several outbreaks of 
the disease were reported (Mostafa, 2001; Abd El-
Lateff, 2006; Ewees, 2007; El-Sissi and Gafer, 2008). 
At Kafr El-Sheikh governorate, 15 outbreaks of vac-
cinated rabbit flocks with signs and lesions similar to 
that of RHDV were investigated (Metwally and Mad-
boully, 2005). Recently, the nucleotide sequencing of 
viral protein (VP60) gene of RHDV was character-
ized from outbreaks of non-vaccinated rabbit flocks 
in different Egyptian governorates (Awad and Kotb, 
2018; Magouzi et al., 2019; Erfan and Shalaby, 2020). 
Infection and transmission
Infection by RHDV occurs mostly through oral, 
nasal, and conjunctival routes. The specific receptors 
of the virus are mainly found in the upper respira-
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tory and digestive tract of susceptible animal (Ru-
voen-Clouet et al., 2000). Transmission of RHDV is 
usually happen through faecal-oral route (Morisse et 
al., 1991). Close contact animals may gain the virus 
through aerosol (Campagnolo et al., 2003). Direct and 
indirect contact with the excreta of infected and dead 
animals are also possible routes of disease transmis-
sion (Ohlinger et al., 1993). The virus remains viable 
for long periods in urine, feces and respiratory secre-
tions (Ohlinger et al., 1993) as well as fur (Mitro and 
Krauss, 1993). The viral RNA of RHDV may persist 
in the environment for 15 weeks, and the recovered 
animal can shed the virus for months. Contaminat-
ed bedding with urine and feces of infected animals 
may also be considered as a source of RHDV (Cooke, 
2002). Furthermore, it has been found that RHDV can 
remain viable and infective on decomposed or dead 
carcass for 12 weeks under harsh environmental con-
ditions (McColl et al., 2002). The lengthy persistence 
of infective RHDV on dead animals may help the dis-
ease spread and outbreaks in the wild (Henning et al., 
2005). The virus can be excreted in the feces of pred-
ators or scavengers that fed on dead infected carcass 
(Merchán yet al., 2011). 
Chilled and frozen rabbit carcasses can carry 
RHDV for several months. An outbreak of RHDV 
in Mixco has been reported due to imported infected 
carcasses from China (Belz, 2004). Due to high sta-
bility of the RHDV and resistance to environmental 
condition, the virus can spread via fomites and con-
taminated food, water, clothes, cages, and equipment 
(Chasey, 1997). 
In addition, insects or flies may play a role in 
transmission of infection as the virus can persist in 
flies for 9 days (Asgari et al., 1998; OIE, 2008). Ro-
dents (Broja and Larios 1990; Xu, 1991), while wild 
animals (Cooke, 2002) are also very important me-
chanical vectors of RHDV. Workers in contact with 
RHDV infected rabbits or with their excretions act 
also as mechanical vectors (CFSPH, 2006).
Susceptibility and clinical disease picture
Domestic (especially European species; Orycto-
lagus Cuniculus) and wild rabbits are susceptible to 
RHD (Gould et al., 1997; Muller et al., 2009; Miao 
et al., 2019; Urakova et al., 2019). Infection of hares 
with variant strain of RHDV (European brown hare 
syndrome virus) has been recorded. However, suscep-
tibility of other leporid species to the virus has not 
been reported (Gregg et al., 1991). Pregnant and lac-
tating does are more susceptible to RHDV infection 
(El-Sissi and Gafer, 2008).
The susceptibility age of rabbits to RHDV is still 
contradicted. The virus can cause higher mortality in 
adults than young kittens as deaths are not common 
in rabbits less than 4-weeks- old. This may be related 
to the presence of specific receptors in adults but not 
in young animals (Dalton et al., 2012). Resistance to 
RHD infection decreases at ages 4-12 weeks. 
The incubation period of RHDV varies from16 to 
48 hours and deaths appear after 2 to 3 days post in-
fection. The disease course may last up to 30 days 
(CFSPH, 2006). The severity of clinical signs differs 
according to the breed of animal, age, immunity, geo-
graphical location, the infecting viral dose and the 
route of infection. 
Sub-clinical infection of RHD is possible in young 
kittens less than 4-8 weeks old. In per-acute stage, 
animals in a good heath conditions, die suddenly 
without prior clinical signs within 12 to 36 hours of 
the disease onset (Belz, 2004). Severe clinical mani-
festations were seen in adults as well as rabbits older 
than 40-50 days of age (Capucci et al., 1991). Acute 
stage of RHD in rabbits is characterized by fever, 
depression, anorexia, conjunctivitis, frothy bloody 
nasal discharge, epistaxis, vulvar hemorrhages in 
pregnant does, severe respiratory distress (cough and 
dyspnea) and finally nervous manifestations (atax-
ia, convulsion, opisthotonos and paralysis) (Xu and 
Chen, 1989; Marcato et al., 1991; Trzeciak-Ryczek 
et al., 2015). Clinical picture associated with variant 
strains of RHDV is similar to classical strains, how-
ever the mortality rate may be comparatively lower 
(Le Gall-Recule et al., 2013). Severe jaundice, ema-
ciation, lethargy, constipation or diarrhea and abdom-
inal distension followed by death within few weeks 
have been observed in sub-acute and chronic stages of 
RHD (Capucci et al., 1991; CFSPH, 2006). Animals 
with sub-acute infection showed mild or minor signs 
with resistance to RHDV re-infection due to develop-
ment of specific antibodies (Patton, 1989; Mitro and 
Krauss, 1993).
The morbidity rate of RHDV varies from 30-
100%, and the mortality rate ranges from 40-100% 
within a period of 2-3 days after infection (Abrantes 
et al., 2012). High morbidity and mortality rates have 
been recorded mainly in adult animals and those kept 
in groups (Mitro and Krauss, 1993). Deaths occur as 
a result of disseminated intravascular coagulopathy 
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resulting in extensive hemorrhages in most organs as 
well as due to necrotizing hepatitis (Marcato et al., 
1991; Plassiart et al., 1992). 
Post-mortem lesions of RHDV infection in rab-
bits have been represented as generalized congestion 
and haemorrhages (Ueda et al., 1992; Marques et al., 
2010), and acute and necrotizing hepatitis (Park et al., 
1995; Alonso et al., 1998; Abrantes et al., 2012). Con-
gestion and ulceration of nasal mucosa, haemothorax, 
frothy exudates in trachea, haemorrhages with multi-
ple abscesses in lungs and pneumonia, splenomegaly, 
subcutaneous abscesses and congestion of the brain 
have also been observed (Eid and Ibraheem, 2006; 
Lavassa and Capucci 2008; Embury-Hyatt et al., 
2012). Severe lesions of RHD appeared in liver, lungs 
and trachea (OIE, 2010). Animals died in sub-acute 
stage showed catarrhal enteritis and icterus. Hamed et 
al. (2013) estimated that severely affected organs as 
liver, lungs, spleen and kidneys in RHD outbreaks are 
the main causes of high mortality.
Histopathological lesions of RHD cases revealed 
severe congested visceral organs, dilated liver sinu-
soids with diffuse and focal hemorrhages and inflam-
matory cells infiltration, severe interstitial pneumonia 
and hemorrhagic alveoli, glomerulonephritis with 
haemorrhages, hemorrhagic tracheitis with sloughed 
mucosal epithelium and hemorrhagic myocarditis 
(Ramiro-Ibáñez et al., 1999; Ferreira et al., 2006; So-
liman et al., 2016). Suppression of immune response 
in RHD infected animals is related to severe decrease 
in number of B and T lymphocytes of the liver and 
spleen (Marques et al., 2010).
Laboratory diagnosis
The diagnosis of RHD depends mainly on the clin-
ical picture, histopathological lesions, detection of the 
virus using electron microscopy, immunostaining and 
molecular characterization and detection of antibod-
ies using haemagglutination (HA) inhibition test and 
Enzyme-Linked Immuno-Sorbent Assay (ELISA) 
(Lavazza and Capucci, 1996).
The first step of laboratory diagnosis of RHDV is 
HA test using human type “O” (Liu et al., 1984; Pu et 
al., 1985; OIE, 2008) or Guinea pig and sheep eryth-
rocytes (Sahar et al., 2011). The sensitivity as well 
as specificity of HA test appear to be inadequate. In 
Egypt, since 2007, variant strains of RHDV are cir-
culating in rabbit’s flocks with typical signs, lesions 
and mortality rate similar to classical RHDV strains 
but these variants are non-haemagglutinating (Ewees, 
2007; El-Sissi and Gafer, 2008). So, the diagnosis of 
RHD may not depend on the HA characters of RHDV 
as some variant strains showed changeable HA as 
negative HA strains have been turned into positive 
ones when passaged in susceptible rabbits (Abd El-
Moaty et al., 2014).
RHD virus is ether and chloroform resistant due 
to lacking of the fatty envelope. The polypeptide of 
60 KDa is enough to classify RHDV as Calicivirus 
(Clouet et al., 1995). The virus of RHD is non-en-
veloped, single-stranded ribonucleic acid (RNA) with 
icosahedral symmetry capsid and diameter 32-44 nm 
(Wang et al., 2013). The virus capsid is containing a 
protein (VP60), that encoded by RHDV genome con-
tains specific antigenic epitope (hypervariable region 
E) (Capucci et al., 1998). The domain P of the virus is 
important for binding to host cells while P2 sub-do-
main is responsible for genetic variation (Wang et al., 
2013). The virus also is a positive-sense RNA that 
contains extra structural proteins (sub-genomic RNA) 
of approximately 2.2 kb which is required for infec-
tion in later stages (Abrantes et al., 2012; Ismail et al., 
2017). The genetic variation between viruses of RHD 
is mainly depends on the sequence of VP60 protein 
(Le Gall-Recule et al., 2003; Forrester et al. 2006’ 
McIntosh et al., 2007; Forrester et al. 2008; Wang et 
al., 2013). 
Strains of RHDV belong to one serotype but the 
virus has a high genetic mutation rate (Gould et al., 
1997). New variant strains of RHDV were detected in 
vaccinated rabbits for the first time in Italy and Ger-
many in 1998 and 1999 (Capucci et al., 1998; Schir-
rmeier et al., 1999). The phylogenetic analysis of 
the strains belonging to RHDV can be classified into 
three groups; classical RHDV with geno-groups G1-
G5, the antigenic variant RHDVa/G6 (Le Gall-Recule 
et al., 2003) and the new type RHDV2/RHDVb (Le 
Gall-Recule et al., 2013).
The liver is considered as the organ of choice for 
detection of RHDV where the highest virus concen-
tration was demonstrated especially in acute or per-
acute disease (Abd El-Motelib, 1993; Ahmad et al., 
2011). High amounts of the virus may also present in 
the secretions and excretions of the infected animals 
as well as the blood. In chronic prolonged stage of 
infection, the virus could be detected in spleen.
Culturing of RHDV on the tissue cultures is dif-
ficult, so detection of the viral gene or antibody are 
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very important for diagnosis (OIE, 2012). Reverse 
Transcriptase-Real Time polymerase Chain Reac-
tion (RT-PCR) is considered as a rapid and sensitive 
method for characterization of specific nucleic acid of 
RHDV (Guittre et al., 1995; Soliman et al., 2016) as 
well as detection of  the viral RNA in the animals’s 
serum (Moss et al., 2002). About 98.7% homolo-
gy in N-terminal part of the capsid protein which is 
conserved portion of RHDV has been detected by 
RT-PCR (Guittre et al., 1995). In situ hybridization 
or RT-Loop-Mediated Isothermal Amplification (RT-
LAMP) assay also was described for detection of 
RHDV RNA in blood, feces and urine.
Inoculation of susceptible animals with RHDV 
can be used experimentally detection of the pathoge-
nicity of the isolated strains.
Prevention and control
Management of RHD outbreaks depends on the 
epidemiological situation of the disease in the region 
and the monitoring process of the field viruses to de-
tect any new genetic and antigenic variants (Abrantes 
et al., 2012). 
Supplementation with hyper-immune antiserum 
used only for prevention of RHD and induces pro-
tection for a short time. Passively acquired immunity 
using hyper immune anti-serum was documented in 
1993 in Egypt, where 4-months-old rabbits were in-
oculated intramuscularly either simultaneously with 
RHDV or before the virus infection. This treatment 
induced protection rate of 100% against RHD (Abd 
El Motelib, 1993). Hyper immune anti-serum may be 
effective only in case of absence of clinical signs of 
infection.
Globally, RHDV vaccines have been developed 
from infected animals ´tissues followed by chemical 
inactivation (Arguello Villares, 1991, Huang, 1991; 
Smid et al., 1991). They have been proved protective 
against variant RHDVa in domestic and wild rabbits 
(Capucci et al., 1998). Due to that the used vaccines 
have many disadvantages like variation of their effi-
cacy according to the physiological conditions of the 
animal (Cabezas et al., 2006) and relatively short pe-
riod of immunity which is not more than 12 months 
(OIE, 2010), so many modified vaccines have been 
developed.
 The prepared RHDV vaccines may be given for 
animals either orally (Bertagnoli et al., 1996a; Pla-
na-Duran et al., 1996; Martin-Alonso et al., 2003; 
Farnos et al., 2005) or intra-nasal (Farnos et al., 
2006). Moreover, bivalent vaccines against myxoma-
tosis (Bertagnoli et al., 1996b; Barcena et al., 2000) 
and pasteurellosis (Peshev and Christova, 2003) have 
been also used. 
Initial trial for production of RHDV vaccine was 
conducted in Egypt by Salem and El-Ballal (1992) as 
inactivated formalized tissue vaccine was produced. 
In this trial, inactivated suspensions of liver and lung 
of RHDV infected animals succeeded in protection of 
inoculated animals 7 days post-vaccination and the im-
munity lasted for more than 2 months. As well, Salem 
and El-Zanaty (1992) tried inactivated tissue derived 
RHDV vaccine for prevention of animals against the 
infection. Other trials were conducted for preparation 
of formalin inactivated, aluminum hydroxide adju-
vanted RHDV vaccine from the Egyptian local strain 
(Egypt 96) (Daoud et al., 1998a) and also prepara-
tion of rabbit pasteurellosis-RHD combined vaccines 
(Daoud et al., 1998b). It has been showed that cell 
culture (Vero cell) inactivated RHDV vaccine is more 
potent than tissue (liver suspension) derived vaccine 
(Khodeir and Daoud, 2002). A bivalent RHDV and 
P. multocida lipopolysaccharides vaccine was also 
developed (Khodeir and Daoud, 2002). Although, 
there are different effective vaccination schedules 
for RHDV prevention, the virus is still circulating 
in rabbitries of Egypt (Abd El-Motelib et al., 1998; 
Metwally and Madbouly, 2005; Abd El-Lateff, 2006; 
Ewees, 2007; El-Sissi and Gafer, 2008; El-Bagoury et 
al., 2014). The local commercial Egyptian vaccines 
(IZOVAC-MEVAX) and (SVRS-Vac) that had been 
used for vaccination of 1.5-months old rabbits against 
RHDV offered 100% protection (Eid and Ibraheem, 
2006). As a result of the endemic situation of the 
RHD among rabbits flocks in Egypt as well as early 
infection of young kittens (40 days old), it has been 
recommended starting vaccination at 1-1.5-months of 
age, followed by another booster dose 15 days later 
and then repeating the vaccination every 4-6 months 
(Eid and Ibraheem, 2006).  
Moreover, due to inadequate application of RHD 
vaccine, non-hemagglutinating RHDVa variant strains 
are circulating in Egyptian rabbits field and infect all 
ages of rabbits (Ewees, 2007; El-Sissi and Gafer, 
2008; Awad and Kotb, 2018). These strains were 
found to cause clinical disease as well as morbidity 
and mortality rates similar to classical RHDV, but 
without HA activity of the virus. Erfan and Shalaby 
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(2020) concluded that there are some limitations re-
garding the effectiveness of currently applied RHDV 
vaccine strains as the vaccine formulation may not 
cover all the circulating strains of the virus in Egypt.
Application of genetically engineered Virus Like 
particle (VLP) of RHDV as a therapeutic strategy for 
treatment of the disease have been studied (El Meh-
daoui et al., 2000; Young et al., 2006; Peacey et al., 
2007, 2008; Crisci et al., 2009; Win et al., 2011). The 
protein of the capsid accumulates in VLP that is dif-
fer from original virions and doesn’t contain the viral 
RNA (Nagesha et al., 1995). This treatment strategy 
considers VLP as immunogenic antigen that stimulate 
both humoral and cell mediate immune responses of 
infected animals (Crisci et al., 2009; Win et al., 2011).
Thorough cleaning and disinfection are a require-
ment for RHDV prevention and control strategies. It 
has been found that the virus can be inactivated using 
disinfectants as 1-2% formalin, 1.0–1.4% formalde-
hyde, 0.2–0.5% beta-propiolactone, 1% sodium hy-
pochlorite, 10% sodium hydroxide or 10 ppm chlo-
rine dioxide (Eleraky et al., 2002). 
All mechanical sources of RHDV infection should 
be also taken into consideration. Field rats and flies 
eradication program should be applied for RHD con-
trol.
In conclusion, to overcome RHD infection in any 
region, constant monitoring of the epidemiological 
status of the disease as well as updating the devel-
opment of local or autogenous vaccines are crucial 
issues that should be thoroughly considered.
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